Experts Answer Questions on the Management of Patients With T-Cell Lymphomas
Listen as expert faculty answer audience questions on the management of patients with T-cell lymphomas posed during a live symposium at the 2022 Hematology Annual Meeting.
Decera Clinical Education Oncology Podcast · Steven M. Horwitz MD, Pamela B. Allen MD, Kerry Savage MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this podcast episode, Steven M. Horwitz, MD; Pamela B. Allen, MD, MSc; and Kerry Savage, MD, MSc, answer questions from an audience of healthcare professionals on topics related to the management of T-cell lymphomas, including:
- Use of brentuximab vedotin in ≤1% CD-30‒expressing lymphomas
- Strategies with JAK inhibition and epigenetic agents
- Allogeneic transplantation in cutaneous T-cell lymphoma
Presenters:
Steven M. Horwitz MD
Member, Memorial Sloan Kettering Cancer Center
Attending Physician, Memorial Hospital
Professor of Medicine, Weill Cornell Medical College
New York, New York
Pamela B. Allen, MD, MSc
Assistant Professor
Department of Hematology/Oncology
Emory University, Winship Cancer Institute
The Emory Clinic
Atlanta, Georgia
Kerry Savage MD, MSc
Professor of Medicine
University of British Columbia
Medical Oncologist
Division of Medical Oncology
BC Cancer
Vancouver, British Columbia, Canada
Content for this program was supported by educational grants from Daiichi Sankyo; Kyowa Kirin, Inc.; and Seagen Inc.
Link to the full program, including downloadable slides, expert commentary, and an on-demand webcast:
bit.ly/3ItqEOd
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.